Context Therapeutics (CNTX) EPS (Basic) (2020 - 2026)
Context Therapeutics (CNTX) posted EPS (Basic) of -$0.19 for Q1 2026, down 13.88% sequentially from -$0.17 in Q4 2025, and down 300.23% YoY from $0.1 in Q1 2025.
Context Therapeutics (CNTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Context Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.19 in Q1 2026.
- Quarterly EPS (Basic) fell 300.23% year-over-year to -$0.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.56 (up 3.95% YoY) and the FY2025 annual result came in at -$0.76, up 13.9% from the prior year.
- EPS (Basic) declined to -$0.19 in Q1 2026 per CNTX's latest filing, from -$0.17 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.05 in Q1 2025 and troughed at -$1.47 in Q4 2023.
- A 5-year average of -$0.35 and a median of -$0.25 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) soared 98.24% in 2022, then sank 300.23% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.82 in 2022, then tumbled by 80.04% to -$1.47 in 2023, then surged by 67.37% to -$0.48 in 2024, then soared by 64.92% to -$0.17 in 2025, then decreased by 13.88% to -$0.19 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.19, -$0.17, and -$0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Context Therapeutics | 49.23 Mn | 49.23 Mn | - | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15 |
| Mar 31, 2026 | -0.19 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -0.48 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -1.47 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -0.82 |
| Sep 30, 2022 | -0.25 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -1.10 |
| Sep 30, 2021 | -4.47 |